Once eligible, patients start biweekly infusions of Leqembi. Some neurologists lack infusion clinics, requiring patients to travel. There are over 850 infusion sites in the U.S., but some states have few. Eisai and Biogen are developing more convenient forms of Leqembi, like monthly infusions or weekly injections. Patients may experience flu-like symptoms initially. Regular MRI scans monitor for side effects like brain swelling. Despite risks, patients like Meeks and Collins find Leqembi beneficial for maintaining daily activities. Long-term benefits are still being evaluated.